Phibro Animal Health CFO David Glenn received 3,482 shares on 2026-08-06, leaving him with 54,959 shares. The award equaled about 6.3% of his resulting holding, giving investors a precise measure of the grant relative to his reported post-transaction position.
Key Highlights
- David Glenn’s reported Phibro Animal Health position stood at 54,959 shares after the award.
- The 3,482-share transaction represented about 6.3% of his resulting holding.
- Transaction code A identified the event as an award or grant.
Phibro Animal Health CFO David Glenn received 3,482 shares on 6 August 2026, bringing his reported post-transaction position to 54,959 shares. The award represented about 6.3% of that resulting holding.
Glenn Receives Award Under Transaction Code A
The reported holding after the transaction was 54,959 shares. The transaction’s stated proportion of that position was about 6.3%. The transaction date was 6 August 2026, and the company named in the record is PHIBRO ANIMAL HEALTH CORP (NASDAQ: PAHC).
FAQs
Q: How many Phibro Animal Health shares did David Glenn receive?
A: David Glenn received 3,482 shares of Phibro Animal Health on 6 August 2026. His reported position after the award was 54,959 shares.
Q: What percentage of David Glenn’s holding did the award represent?
A: The 3,482-share award represented about 6.3% of David Glenn’s resulting Phibro Animal Health holding. The post-transaction total was 54,959 shares.
Q: What does transaction code A mean in David Glenn’s transaction?
A: Transaction code A classified the event as an award or grant. The record identifies David Glenn as Chief Financial Officer of PHIBRO ANIMAL HEALTH CORP.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.